Etiologic diagnosis and epidemiology of chromoblastomycosis
Keywords:
chromoblastomycosis, dematiaceous fungi, dermatomycosisAbstract
Introduction: Chromoblastomycosis is a chronic subcutaneous mycosis caused by a group of dematiaceous fungi; Fonsecaea pedrosoi is one of the most frequent etiological agents and is found in tropical climates with abundant vegetation. The diagnosis is based on three fundamental pillars: clinical-epidemiological, pathological anatomy and microbiological.Objective: to describe the etiological diagnosis and epidemiological variables of interest of the disease in Villa Clara Province during the period from 2003 to 2018.
Methods: descriptive, cross-sectional study in a population of 47 patients. Absolute and relative frequencies were used as summary measures and the Kulldorff technique was used for spatiotemporal exploration.
Results: from the total number of patients, 19% were submitted to mycological studies in which the species Fonsecaea pedrosoi, Cladophialophora carrionii and Phialophora verrucosa were isolated. In the municipality of Manicaragua, a true spatial cluster with a high incidence rate was identified. It was 2.12 times more frequent in men than in women.
Conclusions: in the province there is no clinical, anatomopathological and microbiological integration for the diagnosis of chromoblastomycosis; at least three known etiological agents, Fonsecaea pedrosoi, Cladophialophora carrionii and Phialophora verrucosa, were the cause of the disease during the period studied. The mountainous municipality of Manicaragua constitutes a high-risk geographical area in the province. The sex most affected by the disease was male.
Downloads
References
1. Bonifaz A. Micología Médica Básica. Vol 1. 5ta ed. México: McGraw-Hill Education; 2015.
2. Walsh TJ, Hayden RT, Larone DH. Larone´s Medically Important Fungi. A guide to identification. Vol 1. 6th ed. Estados Unidos: Washington, DC: ASM Press; 2018.
3. Ferrá Torres TM, Florat Gutiérrez D, Flores Salazar SL, Gabriel Coox Y. Cromoblastomicosis. Informe de un caso con localización atípica. Dermatología CMQ [Internet]. 2017 [citado 18/07/2019];15(2):81-83. Disponible en: https://www.medigraphic.com/pdfs/cosmetica/dcm-2017/dcm172d.pdf
4. Queiroz Telles F. Chromoblastomycosis. A neglected tropicaldisease. Rev Inst Med Trop Sao Paulo [Internet]. 2015 [citado 18/07/2019];57(Suppl 19):46-50. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711190/. https://dx.doi.org/10.1590/S0036-46652015000700009
5. Arenas Guzmán R. Micología médica ilustrada. Vol 1. 5ta ed. México: McGraw-Hill; 2014.
6. Moya Duque S. Hongos causantes de cromomicosis. En: Llop Hernández A, Valdés-Dapena MM, Vivanco MG, Zuazo Silva JL. Microbiología y Parasitología Médicas. Ciudad de La Habana: Editorial Ciencias Médicas; 2001. p. 497-499.
7. López López D, Rodríguez Sanz D, Morales Ponce A, Soriano Medrano A. Aproximación al manejo de la patología micótica en el pie. Rev Int Cienc Podol [Internet]. 2015 [citado 18/07/2019];9(1):24-36. Disponible en: https://revistas.ucm.es/index.php/RICP/article/view/47314. http://dx.doi.org/10.5209/rev_RICP.2015.v9.n1.47314
8. Gaviria Giraldo CM, Cardona Castro N. Esporotricosis y cromoblastomicosis: revisión de la literatura. CES Med [Internet]. 2017 [citado 18/07/2019];31(1):77-91. Disponible en: https://www.redalyc.org/pdf/2611/261151838009.pdf. https://doi.org/10.21615/cesmedicina.31.1.8
9. Murray PR, Rosenthal KS, Pfaller MA. Micosis subcutáneas. En: Microbiología Médica. 8va ed. España: Elsevier; 2017. p. 617-626.
10. Flores Salazar SL, Ferrá Torres TM, Florat Gutiérrez D, Gabriel Coox Y. Cromomicosis: presentación de un caso. Archivo Médico Camagüey [Internet]. 2018 [citado 24/07/2019];22(2):224-231. Disponible en: http://revistaamc.sld.cu/index.php/amc/article/view/5545
11. Pérez Blanco M. Cromoblastomicosis en Venezuela, a 100 años de su descubrimiento. Dermatol Venez [Internet]. 2016 [citado 24/07/2019];54(1):9-13. Disponible en: http://revista.svderma.org/index.php/ojs/article/view/1361
12. Kulldorff M. SaTScanTM User Guide [Internet]. Boston: SaTScanTM; 2021 [citado 14/02/2021]. Disponible en: https://www.satscan.org/cgi-bin/satscan/register.pl/SaTScan_Users_Guide.pdf?todo=process_userguide_download
13. Wattiez V, García J, Aquino N, Insaurralde S, Mendoza G, Celia L, et al. Cromomicosis: casuística del Servicio de Dermatología del Hospital Nacional, periodo 1991-2015. Rev Virtual Soc Parag Med Int [Internet]. 2017 [citado 24/07/2019];4(2):27-33. Disponible en: http://scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S2312-38932017000200027. https://doi.org/10.18004/rvspmi/2312-3893/2017.04(02)27-033
14. Rocha H, Gutiérrez G. A propósito de 35 casos observados en el Hospital San Juan de Dios de Bogotá. Rev Fac Med [Internet]. 1972 [citado 24/03/2020];38(1):50-65. Disponible en: https://revistas.unal.edu.co/index.php/revfacmed/article/view/22064/22992
15. Atoche Diéguez CE, Torres Guerrero E, López González R, Arenas R. Panorama epidemiológico de la cromoblastomicosis en el Centro Dermatológico de Yucatán. Dermatol Rev Mex [Internet]. 2016 [citado 24/07/2019];60(6):459-466. Disponible en: https://dermatologiarevistamexicana.org.mx/article/panorama-epidemiologico-de-la-cromoblastomicosis-en-el-centro-dermatologico-de-yucatan/
16. Simón RD, Moya Duque S, Abreu García M. Cromomicosis. Hongos dematiáceos que intervienen en su etiología. Rev Cubana Med [Internet]. 1998 [citado 24/7/2019];37(3):136-140 Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75231998000300002
17. García Gómez D, López Pérez M, Adjudah Truffin C. Diagnóstico microbiológico en un paciente con cromomicosis. Medicentro Electrónica [Internet]. 2020 [citado 22/07/2020];24(3):692-699. Disponible en: http://www.medicentro.sld.cu/index.php/medicentro/article/view/2928/2605
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).